REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study

Abstract

Introduction The purpose of this retrospective study was to compare the effects of two different modalities of administration of the neuro psycho physical optimization (NPPO) neuromodulation treatment, applied with radio electric asymmetric conveyer (REAC) biotechnology devices. Both the modalities are aimed at improving the strategies to deal with and optimize the allostatic response to environmental stressors and exposome. This allows to reduce the dysfunctional adaptive behavior patterns, which underlie many neuropsychological symptoms and pathologies, and to improve the symptoms of depression, anxiety and stress. Materials and Methods From a population of subjects experiencing at least two of the three symptoms depression, anxiety and stress, the selection of pre and post-treatment Depression, Anxiety, Stress 21 items scale (DASS 21) data was made proceeding with a reverse chronological recruitment mechanism, until reaching 150 subjects for each of the 2 groups. The first group was treated with the neuro psycho physical optimization treatment (NPPO), which is the punctiform modality of administration on the auricle pavilion, and the second group was treated with the neuro psycho physical optimization treatment, which is the area modality of administration applied by the planar probe on the cervicobrachial area (NPPO-CB). Results The Wilcoxon signs test confirmed the differences in scores in pre and post-treatment DASS-21. The comparison between the two groups data and the comparison across groups data showed that NPPO and NPPO-CB have the same efficacy in reducing the symptoms of depression, anxiety and stress, after a single treatment cycle. Statistical significance was set at p <0.05. Discussion This is the first efficacy descriptive comparison between the two different modalities of administration of the NPPO treatment, as different options for the same clinical indication.

REAC Neurobiological Modulation as a Precision Medicine Treatment for Fibromyalgia

“…REAC technology has been successfully applied in various medical fields, including pain management [ 26 , 68 , 69 ], depression, anxiety, and stress-related disorders [ 34 , 36 , 37 , 70 , 71 , 72 ], neurological disorders [ 35 , 73 , 74 , 75 , 76 ], orthopedics [ 77 , 78 , 79 , 80 ], wound healing [ 30 , 81 , 82 , 83 ] anti senescence [ 84 , 85 , 86 ] and regenerative medicine [ 31 , 32 , 79 , 87 , 88 , 89 ]. Clinical trials have demonstrated the safety and tolerability of REAC technology, with no significant adverse effects reported.…”

“…Neuro Psycho Physical optimization (NPPO) is a non-invasive, neurobiological modulation treatment. NPPO has been shown to be effective in addressing a range of conditions and symptoms, including chronic pain, anxiety, depression, insomnia, fatigue [ 34 , 36 , 71 , 72 , 92 , 93 , 94 ], and cognitive impairment [ 33 , 74 , 95 ]. These benefits are achieved through the REAC functional optimization of the neurotransmission processes governed by endogenous bioelectrical activity.…”

“…The REAC technology and its neurobiological therapeutic treatments have been extensively studied as a means of addressing the EBA changes [ 26 , 27 , 28 , 29 , 30 ]. The aim of REAC neurobiological treatments is to reorganize EBA at various levels, with the ultimate goal of improving conditions associated with various clinical pictures, including fibromyalgia [ 26 , 27 , 28 , 29 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ].…”